Global Elisa Development Kits Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 2.52 Billion |
 Market Size (Forecast Year) |
USD 4.40 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球酶联免疫吸附试验 (ELISA) 测试市场，按方法（直接 ELISA、间接 ELISA、夹心 ELISA 和竞争性 ELISA）、应用（疫苗开发、免疫学、诊断学、毒理学、药物监测和制药行业和移植、传染病、癌症、蛋白质定量等）、技术（化学发光、比色和荧光）、最终用户（医院和诊断中心以及研究实验室）划分 - 行业趋势和预测到 2031 年。
酶联免疫吸附试验 (ELISA) 测试市场分析和规模
艾滋病毒/艾滋病、肝炎和莱姆病等传染病的发病率不断上升，推动了对 ELISA 检测的需求，以便及早做出准确诊断。正如世卫组织 2022 年 7 月更新的数据所强调的那样，传染病的发病率不断上升，导致对 ELISA 检测等诊断工具的需求增加。截至 2020 年底，全球估计有 3770 万人感染艾滋病毒，其中三分之二以上（2560 万人）居住在非洲地区。此外，登革热已成为全球十大健康威胁之一，过去 50 年来全球发病率增加了 30 倍。世界卫生组织 2022 年 6 月的更新表明，全球有超过 3.54 亿人感染乙型或丙型肝炎。传染病发病率的不断上升凸显了对准确及时诊断的日益增长的需求。
2023 年全球酶联免疫吸附试验 (ELISA) 测试市场规模价值 25.2 亿美元，预计到 2031 年将达到 44 亿美元，2024 年至 2031 年预测期内的复合年增长率为 7.23%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
方法（直接 ELISA、间接 ELISA、夹心 ELISA 和竞争性 ELISA）、应用（疫苗开发、免疫学、诊断学、毒理学、药物监测和制药工业和移植、传染病、癌症、蛋白质定量等）、技术（化学发光、比色和荧光）、最终用户（医院和诊断中心以及研究实验室） |
|
覆盖国家 |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America |
|
Market Players Covered |
Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific (U.S.), ZEUS Scientific, Inc. (U.S.), ALPCO (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Enzo Life Sciences, Inc. (U.S.), Merck KGaA (Germany), BioLegend, Inc. (U.S.), LOEWE Biochemica GmbH (Germany), Creative Diagnostics (U.S.), Arigo biolaboratories Corp. (U.S.), ELISA Technologies, Inc. (U.S.), RayBiotech, Inc. (U.S.), R&D Systems, Inc. (U.S.), AESKU.GROUP GmbH & Co. KG (Germany), Cell Technology (U.S.), Arbor Assays (U.S.), Eurofins Scientific (Luxembourg), Biogenuix (India), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), PerkinElmer Inc. (U.S.), Agilent Technologies (U.S.) |
|
Market Opportunities |
|
Market Definition
ELISA (Enzyme-Linked Immunosorbent Assay) tests are a type of biochemical assay technique used to detect the presence of an antigen or antibody in a sample. This highly sensitive method relies on the interaction between an enzyme-linked antibody or antigen and a substrate to produce a measurable signal, typically a color change. ELISA tests are widely used in medical diagnostics, research laboratories, and the pharmaceutical industry for various purposes, including the detection of infectious diseases, monitoring of drug levels in the blood, and quantification of specific proteins.
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Dynamics
Drivers
- Increasing Prevalence of Chronic and Infectious Diseases
The increasing prevalence of chronic and infectious diseases such as HIV/AIDS, hepatitis, cancer, and autoimmune disorders highlights the critical need for accurate and early diagnosis, a role in which ELISA tests excel. The GLOBOCAN 2020 report indicates that approximately 2,281,658 cases of cancer were recorded in the U.S. in 2020. This number is projected to increase to 3,123,452 cases by 2040. According to the National Diabetes Statistics Report, approximately 37.3 million individuals in the U.S. were diagnosed with diabetes in 2020, with approximately 96 million adults found to have pre-diabetes. As the burden of these diseases continues to rise worldwide, ELISA tests such as elisa test for hiv play a crucial role in disease management and monitoring, making them a fundamental tool in healthcare systems. These diseases require timely and precise monitoring for effective management and treatment, driving the demand for ELISA tests globally.
- Rising Demand for Early and Accurate Disease Diagnosis
There is a rising demand for early and accurate disease diagnosis across various medical fields. ELISA tests are renowned for their high sensitivity and specificity, making them indispensable for early disease detection and monitoring treatment efficacy and increasing application of elisa test. This growing demand for precise diagnostic tools is a major driver for the expansion of the ELISA tests market, as healthcare providers and patients alike seek reliable methods for detecting and managing diseases at their earliest stages.
Opportunities
- Development of Multiplex ELISA Assays
Multiplex assays offer advantages such as reduced sample volume, lower costs, and increased efficiency, making them attractive for various clinical and research applications. The ability to simultaneously measure multiple biomarkers is particularly beneficial in disease profiling and personalized medicine. The development of multiplex ELISA assays, which can detect multiple analytes in a single sample, presents a significant opportunity for market growth.
- Integration of Artificial Intelligence (AI) and Machine Learning
The integration of AI and machine learning technologies in ELISA testing is poised to revolutionize the field. These technologies can improve assay performance, data analysis, and result interpretation, leading to more accurate and efficient ELISA tests. AI and machine learning can also help in identifying complex patterns and trends in large datasets, enhancing the diagnostic capabilities of ELISA test process and driving their adoption in clinical and research settings.
Restraints/Challenges
- High Cost of ELISA Tests
The cost associated with ELISA tests, especially for specialized assays and reagents, is a significant barrier to market growth. The high Elisa test cost may limit their adoption, particularly in resource-limited settings and for routine screening purposes. Efforts to reduce the cost of ELISA tests, such as the development of cost-effective assay kits and reagents, could help overcome this barrier and expand the market reach of ELISA testing.
- Availability of Alternative Technologies
The availability of alternative technologies, such as PCR, next-generation sequencing, and point-of-care testing, poses a challenge to the ELISA tests market. These alternative technologies offer advantages such as faster turnaround times, higher sensitivity, and lower costs, which may limit the growth of the ELISA test market in certain applications. However, continued innovation and advancements in ELISA technology could help maintain its competitiveness in the diagnostic testing landscape.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In December 2022, bispecific antibodies emerged as a notable advancement in the field, targeting two epitopes simultaneously. This approach gained rapid traction among scientists and pharmaceutical manufacturers, with the US FDA and EMA approving four different BsAb drugs for therapeutic use. These bispecific antibodies are primarily aimed at cancer targets, specifically the CD3 pathways
- In September 2022, Neogen Corporation introduced its Veratox VIP assay for cashew detection, marking the second assay in the company's new Veratox VIP line of advanced quantitative ELISA products. Also in September 2022, J Mitra launched its 4th Generation Elisa-based HCV Test, named the HCV Gen 4 Ag & Ab Microlisa. This test is designed for the qualitative detection of HCV core antigen and antibodies against HCV (anti-HCVs) in human serum or plasma
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Scope
The market is segmented on the basis of method, application, technology, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Method
- Direct ELISA
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
Application
- Vaccine Development
- Immunology
- Diagnostics
- Toxicology
- Drug Monitoring and Pharmaceutical Industry
- Transplantation
- Infectious Diseases
- Cancer
- Protein Quantitation
- Others
Technology
- Chemiluminescent
- Colorimetric
- Fluorescent
End User
- Hospitals and Diagnostic Centers
- Research Laboratories
Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, method, application, technology, and end user as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
预计北美将主导市场，原因是
预计亚太地区在预测期内将出现显着增长，原因是
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。
竞争格局和酶联免疫吸附试验 (ELISA) 测试市场份额分析
市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
市场上的一些主要参与者包括：
-
- Ortho-Clinical Diagnostics（美国）
- 赛默飞世尔科技（美国）
- ZEUS Scientific, Inc.（美国）
- ALPCO（美国）
- BD（美国）
- Bio-Rad Laboratories, Inc.（美国）
- 生物梅里埃公司（法国）
- Enzo Life Sciences, Inc.（美国）
- 默克集团（德国）
- BioLegend, Inc.（美国）
- LOEWE Biochemica GmbH（德国）
- Creative Diagnostics（美国）
- Arigo 生物实验室公司（美国）
- ELISA Technologies, Inc.（美国）
- RayBiotech, Inc.（美国）
- R&D Systems, Inc.（美国）
- AESKU.GROUP GmbH & Co. KG（德国）
- Cell Technology（美国）
- Arbor 检测（美国）
- Eurofins Scientific（卢森堡）
- Biogenuix（印度）
- F. Hoffmann-La Roche Ltd（瑞士）
- 雅培（美国）
- 丹纳赫（美国）
- Sysmex 公司 (日本)
- PerkinElmer Inc.（美国）
- 安捷伦科技（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
